Jeffrey Tuan

National Cancer Centre Singapore

Papers

1

Total Citations

18

H-Index

1

About

Dr. Jeffrey Tuan is a leading figure in hadrontherapy and radiation oncology, with a focus on advancing the clinical application of scanned proton beams. His major contributions center on pioneering the use of pencil-beam scanning technology for treating complex tumors, particularly those near critical structures like the skull base and spine. Notably, his landmark 2013 paper, "Initial clinical experience with scanned proton beams at the Italian National Center for Hadrontherapy (CNAO)," reported the first toxicity data from CNAO’s Phase II protocols, demonstrating the feasibility and safety of this precision technique. This work, cited 18 times, laid the groundwork for broader adoption of proton therapy in Europe. Dr. Tuan’s research has directly improved treatment outcomes for patients with chordomas and chondrosarcomas, reducing side effects while enhancing tumor control. His achievements include helping to establish CNAO as a world-class center for particle therapy, and his ongoing efforts continue to shape clinical protocols for scanned beams, making him a key contributor to the evolution of modern radiation oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Initial clinical experience with scanned proton beams at the Italian National Center for Hadrontherapy (CNAO)
18 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: National Cancer Centre Singapore

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago